MicroPort Medical (Shanghai) Acquires Beijing Pangerui Medical Equipment
This article was originally published in PharmAsia News
Executive Summary
MicroPort Medical (Shanghai) announced it acquired Beijing Pangerui Medical Equipment, its first such foray. MicroPort sells mainly cardiac and cerebrovascular products, with its drug-eluting stents accounting for around 30 percent of China's market. Pangerui is a private high-tech firm that offers Shengtang insulin pump as its key product. MicroPort believes the acquisition can enrich its product lines and make it a more comprehensive medical devices company. However, industry analysts note that the company is expanding its performance in preparation for a listing in the U.S., which is expected to raise up to $150 million. (Click here for more - Chinese Language)
You may also be interested in...
Lack Of Industry Involvement In Scoping Process Exacerbates ‘Unworkable’ Timelines
Scientific advice could help companies make up for the lack of involvement in scoping, but slots are in short supply.
Cosmetic And Personal Care Trademark Review: 16 April
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.
Health And Wellness Weekly Trademarks Review: 16 April
Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.